ESSA Pharma
ESSA Pharma Logo
About ESSA Pharma
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. The company specializes in small molecule drugs that disrupt the androgen receptor (AR) signaling pathway, a primary driver of prostate cancer growth. Its lead clinical candidate, masofaniten (formerly EPI-7386), targets the N-terminal domain of the AR, offering a new approach to overcoming resistance mechanisms associated with current AR-targeted therapies.
Address
999 West Broadway, Suite 720
Vancouver, V5Z 1K5
Canada
Year founded
2009
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
